Wei‐Ping Min

机构：Western University, London Health Sciences Centre · ORCID：0000-0001-7389-3194

发表论文 163 篇 · 总被引 6409 次 · h-index 44

代表论文

• miRNA-5119 regulates immune checkpoints in dendritic cells to enhance breast cancer immunotherapy (2020 · Cancer Immunology Immunotherapy · 被引 67)
• Research progress and application opportunities of nanoparticle–protein corona complexes (2021 · Biomedicine & Pharmacotherapy · 被引 66)
• HDAC4 promotes nasopharyngeal carcinoma progression and serves as a therapeutic target (2021 · Cell Death and Disease · 被引 49)
• CRISPR/Cas9 library screening uncovered methylated PKP2 as a critical driver of lung cancer radioresistance by stabilizing β-catenin (2021 · Oncogene · 被引 44)
• CD5 blockade enhances ex vivo CD8 + T cell activation and tumour cell cytotoxicity (2020 · European Journal of Immunology · 被引 44)
• IDO inhibitor synergized with radiotherapy to delay tumor growth by reversing T cell exhaustion (2019 · Molecular Medicine Reports · 被引 41)